Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ADALIMUMAB-RYVK Cause Insurance issue? 19 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Insurance issue have been filed in association with ADALIMUMAB-RYVK (Simlandi). This represents 4.1% of all adverse event reports for ADALIMUMAB-RYVK.

19
Reports of Insurance issue with ADALIMUMAB-RYVK
4.1%
of all ADALIMUMAB-RYVK reports
3
Deaths
2
Hospitalizations

How Dangerous Is Insurance issue From ADALIMUMAB-RYVK?

Of the 19 reports, 3 (15.8%) resulted in death, 2 (10.5%) required hospitalization.

Is Insurance issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB-RYVK. However, 19 reports have been filed with the FAERS database.

What Other Side Effects Does ADALIMUMAB-RYVK Cause?

Off label use (70) Product dose omission issue (67) Crohn's disease (65) Inappropriate schedule of product administration (57) Rheumatoid arthritis (47) Death (45) Diarrhoea (43) Arthralgia (42) Pain (42) Fatigue (39)

What Other Drugs Cause Insurance issue?

CERTOLIZUMAB PEGOL (1,210) HUMAN IMMUNOGLOBULIN G (1,090) LISDEXAMFETAMINE DIMESYLATE (590) RIFAXIMIN (577) LENALIDOMIDE (376) ARIPIPRAZOLE (345) HUMAN C1-ESTERASE INHIBITOR (295) HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (253) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (227) ETANERCEPT (220)

Which ADALIMUMAB-RYVK Alternatives Have Lower Insurance issue Risk?

ADALIMUMAB-RYVK vs ADALIMUMAB\ISOPROPYL ALCOHOL ADALIMUMAB-RYVK vs ADAPALENE ADALIMUMAB-RYVK vs ADAPALENE\BENZOYL PEROXIDE ADALIMUMAB-RYVK vs ADCETRIS ADALIMUMAB-RYVK vs ADDERALL

Related Pages

ADALIMUMAB-RYVK Full Profile All Insurance issue Reports All Drugs Causing Insurance issue ADALIMUMAB-RYVK Demographics